Ignite Creation Date:
2024-05-05 @ 5:35 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00481455
Status:
COMPLETED
Last Update Posted:
2008-11-25
First Post:
2007-05-30
Brief Title:
Phase 2 Study of Panzem Nanocrystal Colloidal Dispersion NCD in Combination With Fixed-Dose Temozolomide to Patients With Recurrent Glioblastoma Multiforme GBM
Sponsor:
CASI Pharmaceuticals Inc
Organization:
CASI Pharmaceuticals Inc